Overview
Availability
- Associate Professor Margaret Cummings is:
- Available for supervision
Fields of research
Works
Search Professor Margaret Cummings’s works on UQ eSpace
2008
Journal Article
The "Fas counterattack" is not an active mode of tumor immune evasion in colorectal cancer with high-level microsatellite instability
Houston, AM, Michael-Robinson, JM, Walsh, MD, Cummings, MC, Ryan, AE, Lincoln, D, Pandeya, N, Jass, JR, Radford-Smith, GL and O'Connell, J (2008). The "Fas counterattack" is not an active mode of tumor immune evasion in colorectal cancer with high-level microsatellite instability. Human Pathology, 39 (2), 243-250. doi: 10.1016/j.humpath.2007.06.010
2007
Journal Article
Genome-wide association study identifies novel breast cancer susceptibility loci
Easton, Douglas F., Pooley, Karen A., Dunning, Alison M., Pharoah, Paul D. P., Thompson, Deborah, Ballinger, Dennis G., Struewing, Jeffery P., Morrison, Jonathan, Field, Helen, Luben, Robert, Wareham, Nicholas, Ahmed, Shahana, Healey, Catherine S., Bowman, Richard, SEARCH collaborators, Meyer, Kerstin B., Haiman, Christopher A., Kolonel, Laurence K., Henderson, Brian E., Marchand, Loic Le, Brennan, Paul, Sangrajrang, Suleeporn, Gaborieau, Valerie, Odefrey, Fabrice, Shen, Chen-Yang, Wu, Pei-Ei, Wang, Hui-Chun, Eccles Diana, Evans, D. Gareth ... Ward, Robyn (2007). Genome-wide association study identifies novel breast cancer susceptibility loci. Nature, 447 (7148), 1087-1093. doi: 10.1038/nature05887
2006
Journal Article
Over-expression of Eph and ephrin genes in advanced ovarian cancer: ephrin gene expression correlates with shortened survival
Herath, Nirmitha I., Spanevello, Mark D., Sabesan, Sabe, Newton, Tanya, Cummings, Margaret, Duffy, Shannon, Lincoln, Douglas, Boyle, Glen, Parsons, Peter G. and Boyd, Andrew W. (2006). Over-expression of Eph and ephrin genes in advanced ovarian cancer: ephrin gene expression correlates with shortened survival. BMC Cancer, 6 (144) 144, 144. doi: 10.1186/1471-2407-6-144
2006
Journal Article
Genetic and Histopathologic Evaluation of BRCA1 and BRCA2 DNA Sequence Variance of Unknown Clinical Significance
Chenevix-Trench, Georgia, Healey, Sue, Lakhani, Sunil, Waring, Paul, Cummings, Margaret, Brinkworth, Ross, Deffenbaugh, Amie M., Burbidge, Lynn Anne, Pruss, Dmitry, Judkins, Thad, Scholl, Tom, Bekessy, Anna, Marsh, Anna, Lovelock, Paul, Wong, Ming, Tesoriero, Andrea, Renard, Helene, Southey, Melissa, Hopper, John L., Yannoukakos, Koulis, Brown, Melissa, kConFab Investigators, Easton, Douglas, Tavtigian, Sean V., Goldgar, David and Spurdle, Amanda B. (2006). Genetic and Histopathologic Evaluation of BRCA1 and BRCA2 DNA Sequence Variance of Unknown Clinical Significance. Cancer Research, 66 (4), 2019-2027. doi: 10.1158/0008-5472.CAN-05-3546
2006
Journal Article
Morphology of breast cancer as a means of triage of patients for BRCA1 genetic testing
Farshid, G, Balleine, RL, Cummings, M, Waring, P and kConFab Grp (2006). Morphology of breast cancer as a means of triage of patients for BRCA1 genetic testing. American Journal of Surgical Pathology, 30 (11), 1357-1366. doi: 10.1097/01.pas.0000213273.22844.1a
2006
Journal Article
Chromogenic in situ hybridisation testing for HER2 gene amplification in breast cancer produces highly reproducible results concordant with fluorescence in situ hybridisation and immunohistochemistry
Bilous, Michael, Morey, Adrienne, Armes, Jane, Cummings, Margaret and Francis, Glenn (2006). Chromogenic in situ hybridisation testing for HER2 gene amplification in breast cancer produces highly reproducible results concordant with fluorescence in situ hybridisation and immunohistochemistry. Pathology, 38 (2), 120-124. doi: 10.1080/00313020600561518
2006
Journal Article
Expression profiling correlates with treatment response in women with advanced serous epithelial ovarian cancer
Newton, Tanya R., Parsons, Peter G., Lincoln, Douglas J., Cummings, Margaret C., Wyld, David K., Webb, Penelope M., Green, Adele C. and Boyle, Glen M. (2006). Expression profiling correlates with treatment response in women with advanced serous epithelial ovarian cancer. International Journal of Cancer, 119 (4), 875-883. doi: 10.1002/ijc.21823
2005
Journal Article
Reduced expression of chemokine (C-C motif) ligand-2 (CCL2) in ovarian adenocarcinoma
Arnold, J. M., Huggard, P. R., Cummings, M., Ramm, G. A. and Chenevix-Trench, G. (2005). Reduced expression of chemokine (C-C motif) ligand-2 (CCL2) in ovarian adenocarcinoma. British Journal of Cancer, 92 (11), 2024-2031. doi: 10.1038/sj.bjc.6602596
2004
Journal Article
Changes in survival after breast cancer: improvements in diagnosis or treatment?
Webb, PM, Cummings, MC, Bain, CJ and Furnival, CM (2004). Changes in survival after breast cancer: improvements in diagnosis or treatment?. Breast, 13 (1), 7-14. doi: 10.1016/S0960-9776(03)00129-2
2003
Journal Article
Fas ligand and tumour counter-attack in colorectal cancer stratified according to microsatellite instability status
Michael-Robinson, Julie M., Pandeya, Nirmala, Cummings, Margaret C., Walsh, Michael D., Young, Joanne P., Leggett, Barbara A., Purdie, David M., Jass, Jeremy R. and Radford-Smith, Graham L. (2003). Fas ligand and tumour counter-attack in colorectal cancer stratified according to microsatellite instability status. Journal of Pathology, 201 (1), 46-54. doi: 10.1002/path.1406
2003
Journal Article
Occult metastases in breast cancer
Cummings, M. C. (2003). Occult metastases in breast cancer. Cancer Forum, 27 (2), 95-97.
2003
Journal Article
Predicting the HER2 status of breast cancer from basic histopathology data: an analysis of 1500 breast cancers as part of the HER2000 International Study
Bilous, M., Ades, C., Armes, J., Bishop, J., Brown, R., Cooke, B., Cummings, M., Farshid, G., Field, A., Morey, A., McKenzie, P., Raymond, W., Robbins, P. and Tan, L. (2003). Predicting the HER2 status of breast cancer from basic histopathology data: an analysis of 1500 breast cancers as part of the HER2000 International Study. Breast, 12 (2), 92-98. doi: 10.1016/S0960-9776(02)00273-4
2002
Journal Article
Occult axillary lymph node metastases in breast cancer do matter: results of 10-year survival analysis
Cummings, M. C., Walsh, M. D., Hohn, B. G, Bennett, I. C., Wright, R. G. and McGuckin, M. A. (2002). Occult axillary lymph node metastases in breast cancer do matter: results of 10-year survival analysis. American Journal of Surgical Pathology, 26 (10), 1286-1295. doi: 10.1097/00000478-200210000-00005
2002
Journal Article
Nuclear PTEN expression and clinicopathologic features in a population-based series of primary cutaneous melanoma
Whiteman, David C., Zhou, Xiao-Ping, Cummings, Margaret C., Pavey, Sandra, Hayward, Nicholas K. and Eng, Charis (2002). Nuclear PTEN expression and clinicopathologic features in a population-based series of primary cutaneous melanoma. International Journal of Cancer, 99 (1), 63-67. doi: 10.1002/ijc.10294
2002
Journal Article
Dominant negative ATM mutations in breast cancer families
Chenevix-Trench, Georgia, Spurdle, Amanda B., Gatei, Magtouf, Kelly, Helena, Marsh, Anna, Chen, Xiaoqing, Donn, Karen, Cummings, Margaret C., Nyholt, Dale, Jenkins, Mark A., Scott, Clare, Pupo, Gulietta M., Dork, Thilo, Bendix, Regina, Kirk, Judy, Tucker, Katherine, McCredie, Margaret R. E., Hopper, John L., Sambrook, Joseph, Mann, Graham J. and Khanna, Kum Kum (2002). Dominant negative ATM mutations in breast cancer families. Journal of the National Cancer Institute, 94 (3), 205-215. doi: 10.1093/jnci/94.3.205
2002
Journal Article
Loss of p16 expression is associated with histological features of melanoma invasion
Pavey, S. J., Cummings, M. C., Whiteman, D. C., Castellano, M., Walsh, M. D., Gabrielli, B. G., Green, A. and Hayward, N. K. (2002). Loss of p16 expression is associated with histological features of melanoma invasion. Melanoma Research, 12 (6), 539-547. doi: 10.1097/01.cmr.0000043154.28051.9f
2001
Journal Article
HER2 testing recommendations in Australia
Bilous, Michael, Ades, Colin, Armes, Jane, Bell, Richard, Brown, Robert, Cook, Bridget, Cummings, Margaret C., Field, Andrew, Llewellyn, Huw, McKenzie, Paul, Raymond, Wendy, Robbins, Peter and Tan, Lisa (2001). HER2 testing recommendations in Australia. Pathology, 33 (4), 425-427. doi: 10.1080/00313020120083133
2001
Journal Article
Reduced expression of intercellular adhesion molecule-1 in ovarian adenocarcinomas
Arnold, J. M., Cummings, M., Purdie, D. and Chenevix-Trench, G. (2001). Reduced expression of intercellular adhesion molecule-1 in ovarian adenocarcinomas. British Journal of Cancer, 85 (9), 1351-1358. doi: 10.1054/bjoc.2001.2075
2000
Journal Article
Mice lacking the vascular endothelial growth factor-B gene (Vegfb) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemia
Bellomo, D., Headrick, J. P., Silins, G. U., Paterson, C. A., Thomas, P. S., Gartside, M., Mould, A., Cahill, M. M., Tonks, I. D., Grimmond, S. M., Wells, C. A., Little, M. H., Cummings, M. C., Hayward, N. K. and Kay, G. F. (2000). Mice lacking the vascular endothelial growth factor-B gene (Vegfb) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemia. Circulation Research, 86 (2), E29-E35.
2000
Journal Article
Expression of p53 in arsenic-related and sporadic basal cell carcinoma
Boonchai, Waranya, Walsh, Michael, Cummings, Margaret and Chenevix-Trench, Georgia (2000). Expression of p53 in arsenic-related and sporadic basal cell carcinoma. Archives of Dermatology, 136 (2), 195-198. doi: 10.1001/archderm.136.2.195
Funding
Past funding
Supervision
Availability
- Associate Professor Margaret Cummings is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Media
Enquiries
For media enquiries about Associate Professor Margaret Cummings's areas of expertise, story ideas and help finding experts, contact our Media team: